Morgan Stanley Starts Contineum Therapeutics (CTNM) at Overweight
Tweet Send to a Friend
(Updated - April 30, 2024 4:46 AM EDT)
Morgan Stanley analyst Jeffrey Hung initiates coverage on Contineum Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst Jeffrey Hung initiates coverage on Contineum Therapeutics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
